Insider · CIK 0002144320
Geoffrey Raymond Oxnard
Files at BLSM (BlossomHill Therapeutics, Inc.). First filing -, latest -.
In brief
Geoffrey Raymond Oxnard files SEC Form 4 as officer at BLSM (BlossomHill Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Geoffrey Raymond Oxnard has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | BLSM BlossomHill Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +61,783 | $0.00 | $0 | 61,783 | Aug 10, 2026 |
Questions about Geoffrey Raymond Oxnard
Answered from the filings on this page, as of the latest one.
Is Geoffrey Raymond Oxnard buying or selling?
Geoffrey Raymond Oxnard has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Geoffrey Raymond Oxnard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Geoffrey Raymond Oxnard has 0.
Where does Geoffrey Raymond Oxnard file Form 4?
Geoffrey Raymond Oxnard has filed Form 4 at BLSM (BlossomHill Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.